Difference between revisions of "Siegel RL, et al. CA Cancer J. Clin. (2019) cited as Ref 1 in DOI: 10.1038/s41392-020-0110-5 (Q9264)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2019, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): CA Cancer J. Clin., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | CA Cancer J. Clin. | ||
| Property / Published In Name String: CA Cancer J. Clin. / rank | |||
| + | Normal rank | ||
Revision as of 20:25, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Siegel RL, et al. CA Cancer J. Clin. (2019) cited as Ref 1 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Siegel RL
0 references
Miller KD
0 references
Jemal A
0 references
2019
0 references
CA Cancer J. Clin.
0 references
